Evidence map›Paper›PMID 30842321›Full record

ArticleJournal of virology2019

Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.

William E Matchett, Stephanie S Anguiano-Zarate, Pramod N Nehete, Kathryn Shelton, Bharti P Nehete, Guojun Yang, Stephanie Dorta-Estremera, Philip Barnette, Peng Xiao, Siddappa N Byrareddy and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. TFrontiers in immunology · 2020
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

William E MatchettVirology and Gene Therapy Graduate Program, Mayo Clinic, Rochester, Minnesota, USA.
Stephanie S Anguiano-ZarateClinical Translational Sciences Graduate Program, Mayo Clinic, Rochester, Minnesota, USA.
Pramod N NeheteDepartment of Comparative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Kathryn SheltonDepartment of Comparative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Bharti P NeheteDepartment of Comparative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Guojun YangDepartment of Oncology Research for Biologics and Immunotherapy Translation, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Stephanie Dorta-EstremeraDepartment of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Philip BarnetteDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Peng XiaoDepartment of Biology, New Iberia Research Center, Lafayette, Louisiana, USA.
Siddappa N ByrareddyDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Francois VillingerDepartment of Biology, New Iberia Research Center, Lafayette, Louisiana, USA.
Ann J HessellDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Nancy L HaigwoodDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
K Jagannadha SastryDepartment of Comparative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston and Bastrop, Texas, USA.
Michael A BarryDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA mab@mayo.edu.
The University of Texas MD Anderson Cancer Center · USOregon National Primate Research Center · USMayo Clinic · USThe University of Texas Health Science Center at Houston · USUniversity of Nebraska Medical Center · USWinnMed · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Samuel Peterson · 2013 to 2026
$6.0M
Vaccine Synergy through Synchronous DeliveryR01AI136718 · NIAID · MAYO CLINIC ROCHESTER · PI BARRY, MICHAEL A, SASTRY, JAGANNADHA K · 2018 to 2020
$2.3M
CD8 T Cell Intrinsic Role of MicroRNA-17~92 in TCR SignalingR03AI113803 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KALIA, VANDANA · 2015 to 2016
$172k
NCATS NIH HHS TL1 TR002380NIAID NIH HHS R01 AI136718NIAID NIH HHS R03 AI113803NIH HHS P51 OD011092NIH HHS U42 OD010426
6 · The paper itself

Abstract

Most human immunodeficiency virus type 1 (HIV-1) infections begin at mucosal surfaces. Providing a barrier of protection at these may assist in combating the earliest events in infection. Systemic immunization by intramuscular (i.m.) injection can drive mucosal immune responses, but there are data suggesting that mucosal immunization can better educate these mucosal immune responses. To test this, rhesus macaques were immunized with replicating single-cycle adenovirus (SC-Ad) vaccines expressing clade B HIV-1 gp160 by the intranasal (i.n.) and i.m. routes to compare mucosal and systemic routes of vaccination. SC-Ad vaccines generated significant circulating antibody titers against Env after a single i.m. immunization. Switching the route of second immunization with the same SC-Ad serotype allowed a significant boost in these antibody levels. When these animals were boosted with envelope protein, envelope-binding antibodies were amplified 100-fold, but qualitatively different immune responses were generated. Animals immunized by only the i.m. route had high peripheral T follicular helper (pTfh) cell counts in blood but low Tfh cell counts in lymph nodes. Conversely, animals immunized by the i.n. route had high Tfh cell counts in lymph nodes but low pTfh cell counts in the blood. Animals immunized by only the i.m. route had lower antibody-dependent cellular cytotoxicity (ADCC) antibody activity, whereas animals immunized by the mucosal i.n. route had higher ADCC antibody activity. When these Env-immunized animals were challenged rectally with simian-human immunodeficiency virus (SHIV) strain SF162P3 (SHIV

Indexed as

AdenoviridaeAdministration, IntranasalAIDS VaccinesAnimalsAntibodies, ViralGene Products, envHIV-1HIV InfectionsImmunity, InnateImmunity, MucosalImmunizationInjections, IntramuscularMacaca mulattaSAIDS VaccinesSimian Immunodeficiency VirusT-Lymphocytes, Helper-InducerAIDS VaccinesAntibodies, ViralGene Products, envSAIDS VaccinesHIV-1mucosalprime-boostreplicatingSHIVsingle-cycle adenovirussystemic

Identifiers

PMID30842321
PMCPMC6498041
OpenAlexW2919475840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.